N -Benzyl-linoleamide, a Constituent of Lepidium meyenii (Maca), Is an Orally Bioavailable Soluble Epoxide Hydrolase Inhibitor That Alleviates Inflammatory Pain

Nalin Singh,Bogdan Barnych,Christophe Morisseau,Karen M. Wagner,Debin Wan,Ashley Takeshita,Hoang Pham,Ting Xu,Abhaya Dandekar,Jun-Yan Liu,Bruce D. Hammock
DOI: https://doi.org/10.1021/acs.jnatprod.0c00938
IF: 5.1
2020-12-15
Journal of Natural Products
Abstract:<span><i>Lepidium meyenii</i> (maca), a plant indigenous to the Peruvian Andes, recently has been utilized globally for claimed health or recreational benefits. The search for natural products that inhibit soluble epoxide hydrolase (sEH), with therapeutically relevant potencies and concentrations, led to the present study on bioactive amide secondary metabolites found in <i>L. meyenii</i>, the macamides. Based on known and suspected macamides, 19 possible macamides were synthesized and characterized. The majority of these amides displayed excellent inhibitory potency (IC<sub>50</sub> ≈ 20–300 nM) toward the recombinant mouse, rat, and human sEH. Quantitative analysis of commercial maca products revealed that certain products contain known macamides (<b>1</b>–<b>5</b>, <b>8</b>–<b>12</b>) at therapeutically relevant total concentrations (≥3.29 mg/g of root), while the inhibitory potency of <i>L. meyenii</i> extracts directly correlates with the sum of concentration/IC<sub>50</sub> ratios of macamides present. Considering both its in vitro efficacy and high abundance in commercial products, <i>N</i>-benzyl-linoleamide (<b>4</b>) was identified as a particularly relevant macamide that can be utilized for in vivo studies. Following oral administration in the rat, compound <b>4</b> not only displayed acceptable pharmacokinetic characteristics but effectively reduced lipopolysaccharide-induced inflammatory pain. Inhibition of sEH by macamides provides a plausible biological mechanism of action to account for several beneficial effects previously observed with <i>L. meyenii</i> treatments.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jnatprod.0c00938?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jnatprod.0c00938</a>.Descriptions of 13 commercial <i>L. meyenii</i> products, normalized extraction efficiencies, analytical method limits of quantitation, sums of abundance/IC<sub>50</sub> ratios, IC<sub>50</sub>s of in vitro positive control, blood concentration profiles of compounds <b>4</b> and <b>5</b>, analgesic efficacy of <b>5</b>, HPLC trace of commercial <i>L. meyenii</i> product extract (E2), and <sup>1</sup>H and <sup>13</sup>C NMR spectra for new compounds (<b>16</b>, <b>17</b>, and <b>19</b>) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jnatprod.0c00938/suppl_file/np0c00938_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.</span>
plant sciences,chemistry, medicinal,pharmacology & pharmacy
What problem does this paper attempt to address?
The paper primarily explores a component extracted from the plant Lepidium meyenii (commonly known as Maca) from the Peruvian Andes—N-benzyl-linoleamide—as a soluble epoxide hydrolase (sEH) inhibitor, its bioactivity, and its effect on alleviating inflammatory pain. The core research questions of the paper can be summarized as follows: 1. **Study on the activity of N-benzyl-linoleamide as an sEH inhibitor**: The authors synthesized a series of potential Maca amides and tested their inhibitory effects on recombinant mouse, rat, and human sEH, finding that most amides exhibited good inhibitory activity. 2. **Analysis of Maca amide content in commercial Maca products**: Through quantitative analysis, researchers identified known Maca amide components in some commercial Maca products, and these components were found to be present at therapeutically relevant concentrations. 3. **Pharmacokinetic study of N-benzyl-linoleamide in vivo**: After oral administration, N-benzyl-linoleamide showed good pharmacokinetic properties in rats and effectively alleviated lipopolysaccharide-induced inflammatory pain. 4. **Potential application value of N-benzyl-linoleamide as an sEH inhibitor**: Given its in vitro activity and high content in commercial products, N-benzyl-linoleamide is considered a natural source sEH inhibitor with practical application potential. In summary, this study aims to validate the efficacy and safety of N-benzyl-linoleamide as a natural source sEH inhibitor and to explore its potential as a therapeutic method for alleviating inflammatory pain.